Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Mirati Therapeutics
company
About
Mirati Therapeutics is a Biotechnology company located in 9363 Towne Centre Dr, San Diego, CA, United States.
- San Diego,California,United States
- 501 - 1000
- http://mirati.com
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $500M
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Dec 13, 1995
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
- Stock Symbol
- nasdaq:MRTX
- Legal Name
- Mirati Therapeutics Inc.
Mirati Therapeutics Inc is a Biotechnology company located in 9363 Towne Centre Dr, San Diego, CA, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$2B
Mirati Therapeutics has raised a total of
$2B
in funding over 2 rounds. Their latest funding was raised on
Nov 10, 2021 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 10, 2021 | Post-IPO Equity | $500M | — | — | — | Detail |
| Oct 26, 2020 | Post-IPO Equity | $0.92B | — | — | — | Detail |
| Jan 8, 2020 | Post-IPO Equity | $345M | — | — | — | Detail |
| Jun 28, 2019 | Post-IPO Equity | $234.30M | — | — | — | Detail |
| Jul 16, 2013 | IPO | — | — | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
2
1
Mirati Therapeutics has made 2 investments. Their most recent investment was on
Sep 13, 2021, when Omneky raised $3M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 13, 2021
Omneky
|
Seed | $3M | Advertising | — |
|
Apr 19, 2021
|
Grant | $4M | Association | Yes |
Employee Profiles
Number of Employee Profiles
11
Mirati Therapeutics has 11 current employee profiles, including
Board member Julie Cherrington
Board member
Executive
Executive
Board member
Executive
Acquisition
Mirati Therapeutics has acquired 1 organizations. Their most recent acquisition was MethylGene on Jun 28, 2013. They acquired MethylGene for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Jun 28, 2013
MethylGene
|
Biopharma | acquisition | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
